Stevanato Group S.p.A. (NYSE:STVN – Get Free Report) has been given an average recommendation of “Moderate Buy” by the five ratings firms that are currently covering the stock, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation, one has assigned a buy recommendation and one has issued a strong buy recommendation on the company.
A number of research firms have recently issued reports on STVN. Wall Street Zen downgraded shares of Stevanato Group from a “buy” rating to a “hold” rating in a research note on Saturday. Jefferies Financial Group set a $17.50 target price on shares of Stevanato Group in a report on Tuesday, February 10th. Morgan Stanley initiated coverage on Stevanato Group in a research note on Monday, December 1st. They set an “equal weight” rating and a $24.00 price target on the stock. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Stevanato Group in a research report on Monday, December 29th.
View Our Latest Report on STVN
Stevanato Group Price Performance
Institutional Trading of Stevanato Group
A number of institutional investors and hedge funds have recently bought and sold shares of STVN. Farther Finance Advisors LLC purchased a new position in shares of Stevanato Group in the third quarter valued at approximately $44,000. GW&K Investment Management LLC lifted its holdings in Stevanato Group by 76.2% during the 4th quarter. GW&K Investment Management LLC now owns 2,440 shares of the company’s stock worth $49,000 after buying an additional 1,055 shares in the last quarter. First Horizon Corp acquired a new stake in Stevanato Group during the 3rd quarter worth approximately $50,000. State of Wyoming boosted its position in Stevanato Group by 39,216.7% in the 2nd quarter. State of Wyoming now owns 2,359 shares of the company’s stock valued at $58,000 after buying an additional 2,353 shares during the period. Finally, Quantbot Technologies LP acquired a new position in shares of Stevanato Group in the third quarter worth $68,000.
Stevanato Group Company Profile
Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.
In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.
Read More
- Five stocks we like better than Stevanato Group
- Energy Security Is Now National Security – Positioning Is Happening Now
- The gold chart Wall Street is terrified of…
- The “Bomb” in America’s Basement
- Unlocked: Elon Musk’s Next Big IPO
- Your Bank Account Is No Longer Safe
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.
